Author

F. C. Holstege

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

J. Drost· 2 shared A. Groenendijk· 1 shared A. Janse· 1 shared B. B. Tops· 1 shared D. F. van der Leest· 1 shared E. Strengman· 1 shared E. T. Verwiel· 1 shared H. H. Kerstens· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Drost

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular characterization reveals subclasses of 1q gain in intermediate-risk Wilms tumors

I. A. van Belzen, M. van Tuil, S. Badloe, E. Strengman, A. Janse, E. T. Verwiel, D. F. van der Leest, S. de Vos, J. L. Baker-Hernandez, A. Groenendijk, R. de Krijger, H. H. Kerstens, J. Drost, M. M. van den Heuvel-Eibrink, B. B. Tops, , J. Y. Hehir-Kwa

The paper identifies subclasses of 1q gain in Wilms tumors by integrating genomic and expression data, revealing differences in mutational mechanisms and functional effects.

bioRxiv · Aug 12, 2022 · PreprintCancer Biology

Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma.

J. DeMartino, M. T. Meister, L. Visser, M. Brok, M. J. A. Groot Koerkamp, L. S. Hiemcke-Jiwa, T. de Souza, J. Merks, F. C. Holstege, T. Margaritis, J. Drost

This study uses single-cell transcriptomics to identify immune suppression and cell states in rhabdomyosarcoma that predict patient outcomes.

bioRxiv · Jul 15, 2022 · PreprintCancer Biology